Georgia Witchel's Mantis Biotech makes Parva, consumer software that reads how a person types and clicks to flag cognitive ...
Caring for patients with ADHD, or those who potentially have ADHD, extends far beyond diagnosis and prescribing.
Long-term ADHD management is rarely about finding one solution that lasts forever”— Dr. Stanford Owen GULFPORT, MS, ...
Morning Overview on MSN
A new non-stimulant ADHD medication just won FDA approval
Attention-deficit/hyperactivity disorder has long been treated mainly with stimulants, and the handful of non-stimulant ...
Once believed to be a condition that children outgrow, attention deficit hyperactivity disorder (ADHD) is now recognized as a ...
The founder economy has spent a decade building tools that assume the operator is a neurotypical inbox processor with ...
An 18-year sibling-design study in Psychiatry Research finds that childhood ADHD more than doubles adult depression risk and ...
Understood reports that the FDA has approved Simtriyo, a new ADHD medication targeting dopamine, norepinephrine, and ...
Simtriyo’s mechanism combines norepinephrine/dopamine augmentation with serotonin modulation, expanding beyond traditional stimulant and selective nonstimulant approaches for heterogeneous ADHD ...
For decades, ADHD was viewed as a childhood condition that mostly affected boys. Researchers now know ADHD manifests ...
ADHD is characterized by symptoms such as inattention, hyperactivity, and impulsivity. But what many people don’t realize is that ADHD also deeply influences executive functions, which are crucial ...
A new study suggests that adult-diagnosed ADHD may not be driven by distinct environmental pathways, with executive function emerging as the clearest link to symptom severity across age-of-diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results